IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
26 hedge funds and large institutions have $34.7M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$572K | |
| 2 | +$136K | |
| 3 | +$46K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.9K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$36.6K |
Top Sellers
| 1 | -$717K | |
| 2 | -$49.9K | |
| 3 | -$28.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$25K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24K |